We use cookies on our website to make it clear, useful and reliable.In order to achieve this and to provide certain personalised features we store a small amount of data about you. To learn more visit Cookies: How we use the information on our website. By navigating from the front page to other sections of our website, you are consenting to information being stored.
Our latest news and events
A new paper funded by the NIHR Maudsley BRC, published today in Oxford Open Immunology, examines prior findings in the field of neuroimmunology that suggest potential treatment strategies for patients suffering long-term symptoms from COVID-19.
Interim analysis of study shows that the NIHR-supported Novavax COVID-19 vaccine is 89.3% effective at preventing COVID-19, including effectiveness against the new variants of concern.
By NIHR Wellcome King's Clinical Research Facility at 29 Jan 2021King’s College London researchers have found evidence that minocycline, a widely used antibiotic with anti-inflammatory properties, gave greater improvement in depressive symptoms in patients with treatment resistant depression with low-grade peripheral inflammation.
By NIHR Maudsley BRC at 28 Jan 2021
King’s College London study assesses the potential impacts of COVID-19 nationwide lockdown on longer term depression, anxiety, and stress in gamblers in the UK.
By NIHR Maudsley BRC at 25 Jan 2021
Loneliness in adults aged 50 and over during the COVID-19 lockdown was linked to worsening depressive and other mental health symptoms, according to a large-scale online study.
By NIHR Maudsley BRC at 22 Jan 2021
The NIHR Maudsley Biomedical Research Centre (BRC) is part of the NIHR and hosted by South London and Maudsley NHS Foundation Trust in partnership with King's College London. We are part of King’s Health Partners Academic Health Sciences Centre.
© NIHR Maudsley Biomedical Research Centre 2024 | Website design by CSMB Design | All rights reserved.
